IPO: Curevac’s mRNA Play For Cures

IPO: Curevac’s mRNA Play For Cures

It all began with an unexpected discovery. CureVac’s founder, Dr. Ingmar Hoerr (a doctoral student at the time), discovered that when it was administered directly into tissue, the historically unstable biomolecule mRNA could be used as a therapeutic vaccine or agent after optimization—no complicated reformulations or molecular packaging needed. With a single discovery, CureVac opened … Read more

Categories IPO

IPO: Relay Therapeutics Plans To Use Big Data For Drug Discovery

IPO: Relay Therapeutics Plans To Use Big Data For Drug Discovery

Relay Therapeutics is a clinical-stage precision medicines company innovating in the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company leverages insights into protein motion and how this dynamic behavior relates to protein function. These insights may enable Relay to more effectively drug protein targets that … Read more

Categories IPO

Berkeley Lights Sets IPO For Its Single Cell Manipulation Platform

The Emeryville, CA-based company will offer 7.4 million shares to raise $126 million at $16 to $18 per share, which translates into a fully diluted market value of $1.2 billion. Berkeley Lights is a leading digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. … Read more

Categories IPO

IPO: Yield10 Bioscience, Inc

IPO: Yield10 Bioscience, Inc

Global food security is a big concept for a small company. To achieve its lofty goals, Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yields. The company has an extensive track record of innovation based around optimizing the flow of carbon in living systems, and it is leveraging … Read more

IPO: Amyris, Inc

IPO: Amyris, Inc

Amyris, Inc is unique in many ways, but a synthetic biology company with a fifteen year history makes it a rare entity in a new, formative-stage industry. In 2005, Amyris partnered with the Bill & Melinda Gates Foundation to engineer yeast to make artemisinic acid, a precursor of artemisinin, an effective anti-malarial drug. In 2008, … Read more

Categories IPO

Twist Bioscience Corporation IPO

Twist Bioscience Corporation IPO

TWIST Bioscience Corp (symbol: TWST) is a leading and rapidly growing synthetic biology company that has developed a DNA synthesis platform to industrialize the engineering of biology. Twist is an “emerging growth company” as defined in Section 2(a) of the Securities Act of 1933, as amended, as modified by the Jumpstart Our Business Startups Act … Read more

Categories IPO